...BRCA1 and BRCA2 mutation carriers. They require extensive information on the counselee and her family history, and thus ...
...BRCA1 and BRCA2 inactivating mutations. Molecular docking was used to screen two chemical libraries: 1) 1,217 FDA approv...
...BRCA1. Dietary intake of folate appears to confer protection against breast cancer through its modulating effects on ER ...
...BRCA1/2-mutation) in 30 patients and contralateral alignment in 1 patient. TiLoop(®) Bra was used in 78 and corial flap ...
...BRCA1 or BRCA2 germline mutation, or a genetic variant of uncertain significance. There was an incidental finding of duc...
...BRCA1-positive breast tumor cells.,We have evaluated the in vitro synergistic effect of combinations of trabectedin and ...
...BRCA1 or BRCA2 mutation, human epidermal growth factor receptor 2 (HER2)+ status, chemotherapy, and radiotherapy were re...
...BRCA1/2 genes; Group 2: women with variants of uncertain significance in BRCA1/2 and Group 3: women with no mutations in...
Many BRCA1 mutation carriers undergo elective surgical oophorectomy (often before menopause) to manage their elevated ri...
Germline inactivating mutations in the BRCA1 and BRCA2 genes are responsible for hereditary breast and ovarian cancer sy...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
